Posted 3/30/09
LSI’s Innovation Partnership targets deadly diseases through novel initiative
Cancer, diabetes, strep infections and neurodegenerative diseases such as Alzheimer’s are the first targets of the Life Sciences Institute’s Innovation Partnership, which shepherds promising biomedical discoveries from labs to the marketplace. Four projects recently were selected for first-round funding totaling $680,000. More >
|